The pharma industry plays an undeniably crucial role in modern medicine. These drugs and therapies, borne out of extensive research and development, have transformed healthcare and saved countless lives. Yet, there exists a paradox: while the importance of medications is evident, trust in the pharmaceutical industry is waning. A significant aspect of this debate revolves around Direct-to-Consumer (DTC) advertising. As trust dips, one can’t help but question: does it still make sense for pharma companies to invest heavily in DTC ads?